OBSOLETE: Cardiac Transplantation

[1]  T. Yun,et al.  Cardiac allograft vasculopathy after heart transplantation: Is it really ominous? , 2017, Clinical transplantation.

[2]  M. Stepanova,et al.  Long‐term outcomes of heart transplant recipients with hepatitis C positivity: the data from the U.S. transplant registry , 2016, Clinical transplantation.

[3]  G. Felker,et al.  Pulmonary Hypertension in the Era of Mechanical Circulatory Support , 2016, ASAIO journal.

[4]  G. Fonarow,et al.  Effect of Hepatitis C Positivity on Survival in Adult Patients Undergoing Heart Transplantation (from the United Network for Organ Sharing Database). , 2016, The American journal of cardiology.

[5]  J. Miro,et al.  An Update on Heart Transplantation in Human Immunodeficiency Virus–Infected Patients , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  P. Leprince,et al.  Performance of gene-expression profiling test score variability to predict future clinical events in heart transplant recipients , 2015, BMC Cardiovascular Disorders.

[7]  L. Lund,et al.  The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report--2015; Focus Theme: Early Graft Failure. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[8]  G. Felker,et al.  Cardiac transplantation for older patients: Characteristics and outcomes in the septuagenarian population. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  Anna K Rieger,et al.  De novo sirolimus with low-dose tacrolimus versus full-dose tacrolimus with mycophenolate mofetil after heart transplantation--8-year results. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  A. Huisman,et al.  Distinct phenotypes of cardiac allograft vasculopathy after heart transplantation: a histopathological study. , 2014, Atherosclerosis.

[11]  J. Fishman,et al.  From the classic concepts to modern practice. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  J. Mullen,et al.  A randomized controlled trial of daclizumab versus anti-thymocyte globulin induction for heart transplantation , 2014, Transplantation research.

[13]  V. Borba,et al.  Bone disease after transplantation: osteoporosis and fractures risk. , 2014, Arquivos brasileiros de endocrinologia e metabologia.

[14]  Stavros G Drakos,et al.  Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials. , 2014, Journal of the American College of Cardiology.

[15]  A. Angelini,et al.  Coronary cardiac allograft vasculopathy versus native atherosclerosis: difficulties in classification , 2014, Virchows Archiv.

[16]  M. Mehra,et al.  Long-term immunosuppression and malignancy in thoracic transplantation: where is the balance? , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  S. Knight,et al.  Graft Vessel Disease Following Heart Transplantation: A Systematic Review of the Role of Statin Therapy , 2014, World Journal of Surgery.

[18]  S. Russell,et al.  Report from a consensus conference on primary graft dysfunction after cardiac transplantation. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[19]  N. Chou,et al.  The effect of statins on cardiac allograft survival. , 2014, Transplantation proceedings.

[20]  M. Farrero,et al.  Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: calcineurin-inhibitors conversion or minimization? , 2014, International journal of cardiology.

[21]  A. Angelini,et al.  The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[22]  M. Ozkan,et al.  The prevalence and course of pulmonary hypertension and right ventricular dysfunction in patients undergoing orthotopic heart transplantation. , 2013, Transplantation proceedings.

[23]  L. Lerman,et al.  Attenuation of cardiac allograft vasculopathy by sirolimus: Relationship to time interval after heart transplantation. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[24]  B. Xiang,et al.  A cardioprotective preservation strategy employing ex vivo heart perfusion facilitates successful transplant of donor hearts after cardiocirculatory death. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[25]  J. Parameshwar,et al.  Use of centrifugal left ventricular assist device as a bridge to candidacy in severe heart failure with secondary pulmonary hypertension. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[26]  P. Macdonald,et al.  Enhanced preservation of the rat heart after prolonged hypothermic ischemia with erythropoietin-supplemented Celsior solution. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[27]  C. Toma,et al.  Optical coherence tomography for characterization of cardiac allograft vasculopathy after heart transplantation (OCTCAV study). , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[28]  F. Fallani,et al.  Differential Effect of Everolimus on Progression of Early and Late Cardiac Allograft Vasculopathy in Current Clinical Practice , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  Jeremiah G. Allen,et al.  Validation of the United States-derived Index for Mortality Prediction After Cardiac Transplantation (IMPACT) using international registry data. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[30]  M. Goddard,et al.  Donor Brain Death Exacerbates Complement-Dependent Ischemia/Reperfusion Injury in Transplanted Hearts , 2013, Circulation.

[31]  P. McCarthy,et al.  Demographic, psychosocial, and behavioral factors associated with survival after heart transplantation. , 2013, The Annals of thoracic surgery.

[32]  T. Billiar,et al.  A novel method of preserving cardiac grafts using a hydrogen-rich water bath. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[33]  D. Mancini,et al.  Randomized Controlled Trial of Sirolimus Conversion in Cardiac Transplant Recipients With Renal Insufficiency , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[34]  M. Loebe,et al.  Usefulness of routine surveillance endomyocardial biopsy 6 months after heart transplantation. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[35]  K. Rufibach,et al.  Statins and the Risk of Cancer After Heart Transplantation , 2012, Circulation.

[36]  Dionne A. Graham,et al.  Racial and Ethnic Differences in Wait-List Outcomes in Patients Listed for Heart Transplantation in the United States , 2012, Circulation.

[37]  D. Fogarty,et al.  Incidence, Determinants, and Outcome of Chronic Kidney Disease After Adult Heart Transplantation in the United Kingdom , 2012, Transplantation.

[38]  F. Fallani,et al.  Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: long-term follow-up of the SHIRAKISS randomized, prospective study. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[39]  D. Yuh,et al.  Simple Score to Assess the Risk of Rejection After Orthotopic Heart Transplantation , 2012, Circulation.

[40]  B. Rybarczyk,et al.  Older patients (age 65+) report better quality of life, psychological adjustment, and adherence than younger patients 5 years after heart transplant: A multisite study. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[41]  P. Aukrust,et al.  Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[42]  M. Domanski,et al.  Histopathology of renal failure after heart transplantation: a diverse spectrum. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[43]  Ashish S Shah,et al.  What predicts long-term survival after heart transplantation? An analysis of 9,400 ten-year survivors. , 2012, The Annals of thoracic surgery.

[44]  M. Crespo-Leiro,et al.  Prevalence and prognostic value of cardiac allograft vasculopathy 1 year after heart transplantation according to the ISHLT recommended nomenclature. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[45]  D. Yuh,et al.  Identifying recipients at high risk for graft failure after heart retransplantation. , 2012, The Annals of thoracic surgery.

[46]  E. E. David,et al.  The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT): a new tool for the psychosocial evaluation of pre-transplant candidates. , 2012, Psychosomatics.

[47]  R. Shemin,et al.  Donor-recipient sex mismatch portends poor 10-year outcomes in a single-center experience. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[48]  M. Konstam,et al.  Outcomes in patients with symptomatic cerebrovascular disease undergoing heart transplantation. , 2011, Journal of the American College of Cardiology.

[49]  M. Mehra,et al.  Current and future challenges in therapy for antibody-mediated rejection. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[50]  J. Saucedo,et al.  Drug eluting versus bare metal stents in cardiac allograft vasculopathy , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[51]  M. Russo,et al.  Standard versus bicaval techniques for orthotopic heart transplantation: an analysis of the United Network for Organ Sharing database. , 2010, The Journal of thoracic and cardiovascular surgery.

[52]  D. Mancini,et al.  Factors Associated With Primary Graft Failure After Heart Transplantation , 2010, Transplantation.

[53]  A. Boyle,et al.  Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices. , 2010, The Journal of thoracic and cardiovascular surgery.

[54]  Clive Lewis,et al.  The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[55]  R. Starling,et al.  International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[56]  James Yee,et al.  Gene-expression profiling for rejection surveillance after cardiac transplantation. , 2010, The New England journal of medicine.

[57]  M. Oz,et al.  The Effect of Body Mass Index on Survival Following Heart Transplantation: Do Outcomes Support Consensus Guidelines? , 2010, Annals of surgery.

[58]  J. Fishman.  Introduction: Infection in Solid Organ Transplant Recipients , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[59]  S. Russell,et al.  Impact of recipient body mass index on organ allocation and mortality in orthotopic heart transplantation. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[60]  W. Kremers,et al.  Combined Heart and Liver Transplantation: A Single-Center Experience , 2009, Transplantation.

[61]  N. Uriel,et al.  Heart transplantation in human immunodeficiency virus-positive patients. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[62]  N. Banner,et al.  Chronic kidney disease after heart transplantation. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[63]  P. Macdonald.  Heart transplantation: who should be considered and when? , 2008, Internal medicine journal.

[64]  R. Hinojosa Pérez,et al.  Prognosis after heart transplant in patients with pulmonary hypertension secondary to cardiopathy. , 2008, Transplantation proceedings.

[65]  D. Renlund,et al.  Impact of dose reductions on efficacy outcome in heart transplant patients receiving enteric‐coated mycophenolate sodium or mycophenolate mofetil at 12 months post‐transplantation , 2008, Clinical transplantation.

[66]  R. Shemin,et al.  Long-term outcomes of heart transplantation in older recipients. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[67]  G. Tenderich,et al.  Impact of recipient's age on heart transplantation outcome. , 2008, The Annals of thoracic surgery.

[68]  R. Hetzer,et al.  Enteric-coated mycophenolate-sodium in heart transplantation: efficacy, safety, and pharmacokinetic compared with mycophenolate mofetil. , 2008, Transplantation proceedings.

[69]  T. Wahlers,et al.  Marginal donor grafts in heart transplantation: lessons learned from 25 years of experience , 2007, Transplant international : official journal of the European Society for Organ Transplantation.

[70]  C. Parkinson,et al.  Management of solid tumours in organ-transplant recipients. , 2007, The Lancet. Oncology.

[71]  A. Hoffmeier,et al.  Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices. , 2007, The Annals of thoracic surgery.

[72]  Yoshifumi Naka,et al.  Survival After Heart Transplantation Is Not Diminished Among Recipients With Uncomplicated Diabetes Mellitus: An Analysis of the United Network of Organ Sharing Database , 2006, Circulation.

[73]  Stuart Russell,et al.  Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[74]  D. Renlund,et al.  Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: results of a 12-month, single-blind, randomized, parallel-group, multicenter study. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[75]  G. Ewald,et al.  Tacrolimus with Mycophenolate Mofetil (MMF) or Sirolimus vs. Cyclosporine with MMF in Cardiac Transplant Patients: 1‐Year Report , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[76]  M. Frigerio,et al.  Superior Prevention of Acute Rejection by Tacrolimus vs. Cyclosporine in Heart Transplant Recipients—A Large European Trial , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[77]  J. Kobashigawa,et al.  Immunosuppression for heart transplantation: where are we now? , 2006, Nature Clinical Practice Cardiovascular Medicine.

[78]  J. Lekakis,et al.  Impact of cardiac transplantation in 24 hours circadian blood pressure and heart rate profile. , 2005, Transplantation proceedings.

[79]  M. Schnitzler,et al.  Guidelines for the treatment and management of new‐onset diabetes after transplantation 1 , 2005, Clinical transplantation.

[80]  D. Renlund,et al.  Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[81]  H. Arendrup,et al.  Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[82]  D. Renlund,et al.  Percutaneous coronary interventions with stents in cardiac transplant recipients. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[83]  R. Pierson,et al.  Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[84]  L. Mestroni,et al.  Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs. , 2004, Circulation.

[85]  L. Mestroni,et al.  Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs. , 2004, Circulation.

[86]  P. Macdonald,et al.  Sirolimus in De Novo Heart Transplant Recipients Reduces Acute Rejection and Prevents Coronary Artery Disease at 2 Years: A Randomized Clinical Trial , 2004, Circulation.

[87]  P. Marchetti.  New-onset diabetes after transplantation. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[88]  E. Tuzcu,et al.  Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. , 2003, The New England journal of medicine.

[89]  J. Kobashigawa,et al.  Retransplantation in 7,290 primary transplant patients: a 10-year multi-institutional study. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[90]  M. Czerny,et al.  Long-term survival (>10 years) of patients >60 years with induction therapy after cardiac transplantation. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[91]  J. Hosenpud,et al.  MYCOPHENOLATE MOFETIL VERSUS AZATHIOPRINE IN PATIENTS SURVIVING THE INITIAL CARDIAC TRANSPLANT HOSPITALIZATION: AN ANALYSIS OF THE JOINT UNOS/ISHLT THORACIC REGISTRY , 2001, Transplantation.

[92]  M. Oz,et al.  PRETRANSPLANT CACHEXIA AND MORBID OBESITY ARE PREDICTORS OF INCREASED MORTALITY AFTER HEART TRANSPLANTATION1 , 2001, Transplantation.

[93]  R. Wilson,et al.  Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. , 1995, Journal of the American College of Cardiology.

[94]  A. Carpentier,et al.  Total orthotopic heart transplantation: an alternative to the standard technique. , 1991, The Annals of thoracic surgery.

[95]  M. Gassmann,et al.  Moderate hypothermia during ex vivo machine perfusion promotes recovery of hearts donated after cardiocirculatory death†. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[96]  M. Hannan,et al.  The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[97]  B. Needleman,et al.  Laparoscopic sleeve gastrectomy in morbidly obese patients with end-stage heart failure and left ventricular assist device: medium-term results. , 2015, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[98]  S. Russell,et al.  Insurance and education predict long-term survival after orthotopic heart transplantation in the United States. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[99]  R. Hetzer,et al.  Tacrolimus versus cyclosporine microemulsion for heart transplant recipients: a meta-analysis. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[100]  L. Sade,et al.  Dobutamine stress echocardiography in the assessment of cardiac allograft vasculopathy in asymptomatic recipients. , 2008, Transplantation proceedings.

[101]  S. Heymsfield,et al.  Excessive weight gain in cardiac transplant recipients. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.